معرفی
Dr. Andrew McGuire is an Associate Professor in the Immunology and Vaccine Development Program within the Vaccine and Infectious Disease Division at Fred Hutchinson Cancer Center. He is also a Member of the Pathogen-Associated Malignancies Integrated Research Center (PAM IRC). His research focuses on designing vaccines against viral pathogens of significant public health importance, particularly HIV-1, Epstein-Barr virus (EBV), Kaposi sarcoma-associated herpesvirus, and respiratory syncytial virus (RSV).
Dr. McGuire's educational background includes:
- PhD in Molecular and Cellular Biology from the University of Guelph, Ontario (2011)
- BSc in Molecular Biology and Genetics from the University of Guelph (2004)
Dr. McGuire's research program centers on understanding protective antibody responses to viral antigens and using this knowledge to design and test safe and effective vaccines. His laboratory isolates monoclonal antibodies from naturally infected individuals to identify critical sites of vulnerability on viruses. This structural information guides the development of next-generation vaccine antigens using nanoparticle display, mRNA vaccine technologies, and machine-learning design approaches. A key focus of his work is developing immunogens that can elicit broadly neutralizing antibodies against rapidly mutating viruses like HIV-1, which could provide protection against multiple viral strains.
Analysis of Dr. McGuire's recent publications reveals a strong emphasis on structural approaches to vaccine design, with significant focus on EBV and RSV. His work combines structural biology, immunology, and computational approaches to develop novel vaccine strategies that target critical viral vulnerabilities. The research shows progression from basic antibody characterization to preclinical vaccine testing, with increasing sophistication in antigen design approaches.
Dr. McGuire has received recognition for his work, including being named an Evergreen Fund Awardee in 2025. His research has been featured in numerous publications and news outlets highlighting advances in viral vaccine development.
Dr. McGuire mentors several graduate students and postdoctoral researchers in his laboratory. His collaborative approach to research has led to productive partnerships with structural biologists and other experts in virology and immunology across the Seattle research community.
The McGuire Lab maintains active research programs in multiple areas of viral immunology and vaccine development, with particular emphasis on translating basic scientific discoveries into practical vaccine candidates that can prevent viral infections and associated diseases.
